Core Insights - Cognizant Technology Solutions (CTSH) reported non-GAAP earnings of $1.23 per share for Q1 2025, exceeding the Zacks Consensus Estimate by 3.36% and reflecting a year-over-year increase of 9.8% [1] - Revenues reached $5.12 billion, surpassing the consensus mark by 0.95%, with a year-over-year growth of 7.5% and 8.2% at constant currency [1] - The Belcan acquisition contributed approximately 400 basis points to revenue growth, while bookings increased 3% year over year to $26.7 billion, indicating a book-to-bill ratio of about 1.3 times [2] Financial Performance - Financial services revenues, accounting for 28.6% of total revenues, grew 5.6% year over year to $1.462 billion, driven by increased discretionary spending and investments in cloud and AI [4] - Health Sciences revenues, making up 30.7% of total revenues, rose 10.9% year over year to $1.571 billion, supported by strong demand across various sectors [5] - Products and Resources revenues increased 12.8% year over year to $1.27 billion, while Communications, Media and Technology revenues decreased 2.7% to $804 million [5] Regional Performance - North America contributed 75.3% to total revenues, with a year-over-year increase of 9.5% [6] - Revenues from Europe grew 1.2% year over year, contributing 18.6% to total revenues, while the Rest of the World saw a 3.7% increase [6] Operational Metrics - Selling, general & administrative expenses as a percentage of revenues decreased by 60 basis points year over year to 15.5% [7] - The company reported a GAAP operating margin of 16.7%, expanding 210 basis points year over year, and a non-GAAP operating margin of 15.5%, which expanded 40 basis points [8] Balance Sheet Overview - As of March 31, 2025, cash and short-term investments totaled $1.99 billion, down from $2.24 billion at the end of 2024 [9] - Total debt decreased to $600 million from $908 million, while cash generated from operations was $400 million compared to $920 million in the previous quarter [9] Future Guidance - For Q2 2025, revenues are expected to be between $5.14 billion and $5.21 billion, indicating growth of 5.9%-7.4% [10] - For the full year 2025, revenues are projected to be in the range of $20.5-$21 billion, reflecting an increase of 3.9-6.4% [10] - Adjusted earnings per share for 2025 are anticipated to be between $4.98 and $5.14 [11]

Core Insights - Cognizant reported revenue of $5.12 billion for the quarter ended March 2025, reflecting a year-over-year increase of 7.5% and surpassing the Zacks Consensus Estimate by 0.95% [1] - The earnings per share (EPS) for the quarter was $1.23, up from $1.12 in the same quarter last year, exceeding the consensus EPS estimate of $1.19 by 3.36% [1] Financial Performance by Segment - Financial Services revenue was $1.46 billion, exceeding the average estimate of $1.43 billion, with a year-over-year increase of 5.6% [4] - Communications, Media and Technology revenue was $804 million, below the estimated $833.33 million, representing a year-over-year decline of 2.7% [4] - Products and Resources revenue reached $1.28 billion, slightly above the estimated $1.27 billion, with a year-over-year increase of 12.8% [4] - Health Sciences revenue was $1.57 billion, surpassing the average estimate of $1.55 billion, reflecting a year-over-year growth of 11% [4] Stock Performance - Cognizant's shares have returned -4.1% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Group 1 - Cognizant reported quarterly earnings of $1.23 per share, exceeding the Zacks Consensus Estimate of $1.19 per share, and up from $1.12 per share a year ago, representing an earnings surprise of 3.36% [1] - The company achieved revenues of $5.12 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.95%, and an increase from $4.76 billion year-over-year [2] - Cognizant has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Group 2 - The stock has experienced a decline of approximately 4.7% since the beginning of the year, compared to a decline of 5.5% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $1.23 on revenues of $5.12 billion, and for the current fiscal year, it is $4.96 on revenues of $20.57 billion [7] - The Computers - IT Services industry, to which Cognizant belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges ahead [8]

Financial Performance - Revenues for Q1 2025 increased to $5,115 million, up 7.4% from $4,760 million in Q1 2024[20] - Net income for Q1 2025 was $663 million, representing a 21.4% increase compared to $546 million in Q1 2024[20] - Basic and diluted earnings per share for Q1 2025 were both $1.34, up from $1.10 in Q1 2024[20] - Comprehensive income for Q1 2025 was $794 million, compared to $484 million in Q1 2024[23] - Operating income increased by 22.7% to $853 million in Q1 2025, compared to $695 million in Q1 2024[113] - Adjusted income from operations rose by $73 million or 10.2% from Q1 2024[106] - Operating margin for Q1 2025 improved to 16.7%, up from 14.6% in Q1 2024, driven by net savings from the NextGen program and operational efficiencies[107] - Adjusted diluted EPS increased by 9.8% to $1.23 in Q1 2025, compared to $1.12 in Q1 2024[113] Revenue Breakdown - North America contributed $3,854 million to total revenues in Q1 2025, up from $3,521 million in Q1 2024, reflecting a growth of about 9.5%[36] - The Health Sciences and Financial Services segments contributed positively to revenue growth, while the Products and Resources and Communications, Media and Technology segments showed weakness[107] - Revenue for Q1 2025 increased by $355 million or 7.5% compared to Q1 2024, with an 8.2% increase in constant currency[106] - Recent acquisitions contributed 400 basis points to overall revenue growth, with a significant impact on the Products and Resources segment[117] Cash Flow and Assets - Cash generated from operating activities in Q1 2025 was $400 million, a significant increase of $305 million compared to $95 million in Q1 2024[150] - Total current assets as of March 31, 2025, were $7,545 million, slightly up from $7,504 million at the end of 2024[17] - Cash and cash equivalents at the end of Q1 2025 were $1,980 million, down from $2,231 million at the end of 2024[17] - Long-lived assets as of March 31, 2025, totaled $988 million, slightly down from $994 million as of December 31, 2024[101] Liabilities and Debt - Total liabilities decreased to $5,068 million as of March 31, 2025, down from $5,558 million at the end of 2024[17] - Long-term debt as of March 31, 2025, is $567 million, down from $875 million as of December 31, 2024, reflecting a decrease of 35.2%[52] - The company repaid $300 million of its revolving credit facility during Q1 2025, following a $600 million borrowing in Q3 2024 to fund the acquisition of Belcan[48] Tax and Legal Matters - The effective income tax rate for the three months ended March 31, 2025, is 24.4%, slightly down from 24.8% in the same period of 2024[53] - The company is involved in ongoing disputes with the Indian Tax Department regarding share repurchase transactions valued at $523 million and $2.8 billion from 2013 and 2016, respectively[53] - The ongoing legal proceedings related to Syntel resulted in a reduced damages award from $855 million to $570 million, with further evaluations pending[78] Operational Efficiency - The company reported a decrease in operational costs by H%, improving overall profitability[179] - Voluntary attrition in Tech Services was 15.8% for the trailing twelve months ended March 31, 2025, compared to 13.1% for the same period in 2024[108] Future Outlook and Investments - The company plans to continue significant investments in AI capabilities to meet client needs and enhance internal operations[110] - Market expansion efforts are underway, with plans to enter E new markets by the end of the year[179] - The company is considering strategic acquisitions to enhance its market position, with a budget of $F million earmarked for potential deals[179] Shareholder Returns - Dividends declared in Q1 2025 were $0.31 per share, totaling $154 million[26] - A dividend of $0.31 per share was declared on April 29, 2025, with a record date of May 19, 2025[103] - The company repurchased $190 million of its Class A common stock during Q1 2025, with a remaining balance of $3,047 million authorized for repurchase[173][174]

Financial Data and Key Metrics Changes - First quarter revenue grew by 8.2% year over year in constant currency to $5.1 billion, driven by the Belcan acquisition and organic growth in Health Sciences and Financial Services [6][25] - Adjusted Operating Margin improved by 40 basis points year over year to 15.5%, on track to achieve full year guidance of 20 to 40 basis points of expansion [8][33] - Adjusted EPS grew 10% year over year, marking the sixth consecutive quarter of year over year growth [8][25] Business Line Data and Key Metrics Changes - Health Sciences revenue increased over 11% year over year in constant currency, with broad-based growth across payer, provider, and life sciences [7][28] - Financial Services segment grew 6.5% year over year in constant currency, with healthy discretionary spending as clients invested in cloud and data modernization [7][28] - Products and Resources segment growth was driven by Welch, but faced weak demand due to discretionary spending pressures [29] Market Data and Key Metrics Changes - North America revenue grew 10% year over year in constant currency, driven by Belcan and large deals [30] - Europe revenue increased by 3% year over year in constant currency, supported by life sciences and financial services clients [31] - The Rest of the World saw a 7% year over year increase in constant currency, driven by large deals in Communications, Media, and Technology [32] Company Strategy and Development Direction - The company is investing heavily in AI-powered software-led engineering, integrating expertise in embedded software and IoT with capabilities from recent acquisitions [10][19] - Strategic imperatives include amplifying talent, scaling innovation, and accelerating growth, with a focus on AI and embedded engineering [16][19] - The company aims to build resilience and durability by developing leadership and talent, strengthening operational discipline, and rebooting innovation [9][10] Management's Comments on Operating Environment and Future Outlook - The macro environment changed sharply in early April, leading to elevated uncertainty, but the company sees opportunities related to productivity and efficiency [9][26] - Management remains optimistic about capturing demand in Financial Services and believes the current environment presents opportunities for cost optimization [27] - The company expects revenue growth of 5% to 6.5% year over year in constant currency for the second quarter of 2025 [35][36] Other Important Information - The company had four large deals in the first quarter, including a mega deal valued at over $500 million [8][26] - Free cash flow for the first quarter was $393 million, with plans to redeploy proceeds from the sale of an office complex in India [35] - The company plans to return approximately $1.7 billion to shareholders in 2025, including $1.1 billion in share repurchases and $600 million in dividends [39] Q&A Session Summary Question: Insights on bookings and pipeline shifts - Management noted that productivity gains from leveraging AI are leading to new deals and opportunities for consolidation, particularly in financial services [43][44] Question: Impact of April slowdown on decision-making - Management indicated that the slowdown is primarily seen in the Products and Resources segment, while Financial Services remains strong [56][57] Question: Comfort level regarding backlog coverage - Management expressed confidence in the backlog coverage, with a book-to-bill ratio of 1.3x and healthy demand in applications, AI, and cybersecurity [76] Question: Gross margin trends and expectations - Management highlighted that cost discipline will drive operating margin outcomes, with utilization and productivity improvements being key factors [78] Question: Sustainability of current growth and market position - Management emphasized the need for consistency in performance and expressed confidence in sustaining growth through a broad-based portfolio and strong market position [85][86]

Financial Data and Key Metrics Changes - First quarter revenue grew by 8.2% year over year in constant currency to $5,100 million, driven by the Belcan acquisition and organic growth in Health Sciences and Financial Services [6][25] - Adjusted Operating Margin improved by 40 basis points year over year to 15.5%, on track to achieve full year guidance of 20 to 40 basis points of expansion [8][32] - Adjusted EPS grew 10% year over year, marking the sixth consecutive quarter of year over year growth [8][25] Business Line Data and Key Metrics Changes - Health Sciences revenue increased over 11% year over year in constant currency, with broad-based growth across payer, provider, and life sciences [7][28] - Financial Services segment grew 6.5% year over year in constant currency, with healthy discretionary spending as clients invested in cloud and data modernization [7][28] - Products and Resources segment growth was driven by Welch, but overall demand environment remained weak due to discretionary spending pressures [29] Market Data and Key Metrics Changes - North America revenue grew 10% year over year in constant currency, driven by Belcan and large deals [30] - Europe revenue increased by 3% year over year in constant currency, supported by life sciences and financial services clients [30] - The Rest of the World saw a 7% year over year increase in constant currency, driven by large deals in Communications, Media, and Technology [31] Company Strategy and Development Direction - The company is investing heavily in AI-powered software-led engineering, integrating expertise in embedded software and IoT with capabilities from recent acquisitions [10][21] - Strategic imperatives include amplifying talent, scaling innovation, and accelerating growth, with a focus on AI and embedded engineering [16][19] - The company aims to build a resilient and durable organization that can thrive in both slow and high-velocity markets [5][9] Management's Comments on Operating Environment and Future Outlook - The macro environment has changed sharply, leading to elevated uncertainty, but the company sees opportunities related to productivity and efficiency [9][26] - Management remains optimistic about the pipeline for large deals and believes the current environment presents opportunities for cost optimization and vendor consolidation [26][39] - The company expects revenue growth of 3.5% to 6% in constant currency for the full year 2025, with adjusted operating margin guidance of 15.5% to 15.7% [36][37] Other Important Information - The company has approximately 1,400 early Gen AI engagements, reflecting a strong focus on AI-led productivity [11][12] - The company plans to establish a 14-acre immersive learning center in Chennai, India, to train 100,000 individuals annually in advanced AI technologies [17][20] - The company returned $364 million of capital to shareholders through share repurchases and dividends during the quarter [35] Q&A Session Summary Question: Shift in bookings and pipeline quality - Management noted that productivity gains from leveraging AI are leading to new deals and opportunities for consolidation, particularly in financial services [42][44] Question: April slowdown in decision-making - Management indicated that while there is some caution in health and products and resources sectors, financial services remain strong, and the impact is seen as isolated [56][57] Question: Organic growth and headcount changes - Management confirmed that organic growth has been driven by healthcare and financial services, with a significant improvement in utilization from 82% to 85% [64][90] Question: Confidence in cost takeout deals - Management expressed confidence that the current environment is conducive for closing cost takeout deals, despite some delays in mega deals [93]

Financial Performance - Cognizant's Q1 2025 revenue reached $5115 million, a 7.5% increase year-over-year as reported, or 8.2% in constant currency[5] - The company's GAAP diluted EPS for Q1 2025 was $134, compared to $110 in Q1 2024[7] - Cognizant's GAAP operating margin increased to 167% in Q1 2025, up from 146% in Q1 2024[9] - Operating cash flow for Q1 2025 was $400 million, a significant increase from $95 million in Q1 2024[11] - Free cash flow for Q1 2025 was $393 million, compared to $16 million in Q1 2024, which includes a $70 million positive impact from the sale of property and equipment[11, 48] Segment Performance - Health Sciences revenue reached $1571 million in Q1 2025, a 109% increase year-over-year, or 114% in constant currency[18] - Financial Services revenue was $1462 million in Q1 2025, a 56% increase year-over-year, or 65% in constant currency[18] - Products & Resources revenue was $1278 million in Q1 2025, a 128% increase year-over-year, or 136% in constant currency, with acquisitions contributing approximately 15 percentage points to this growth[18, 19] - Communications, Media & Technology revenue was $804 million in Q1 2025, a 27% decrease year-over-year, or 19% in constant currency[18] Bookings and Guidance - Trailing twelve-month bookings reached $267 billion, a 3% increase year-over-year, representing a book-to-bill ratio of 13x[44] - The company projects full-year 2025 revenue to be approximately $205 to $210 billion, representing a 39% to 64% year-over-year increase, or 35% to 60% in constant currency[49]

Revenue Performance - Revenue for Q1 2025 was $5,115 million, a 7.5% increase year-over-year, and 8.2% in constant currency[3] - Revenues for Q1 2025 were $5,115 million, a 7.4% increase from $4,760 million in Q1 2024[28] - Total revenues for the three months ended March 31, 2025, were $5,115 million, representing a year-over-year increase of 7.5%[39] - Full-year 2025 revenue is expected to be between $20.5 billion and $21.0 billion, representing growth of 3.9% to 6.4%[12] - Q2 2025 revenue guidance is set between $5.14 billion and $5.21 billion, indicating growth of 5.9% to 7.4%[12] Profitability Metrics - GAAP operating margin improved to 16.7%, up 210 basis points year-over-year, while adjusted operating margin increased to 15.5%, up 40 basis points[6] - GAAP diluted EPS rose to $1.34, a 22% increase year-over-year, and adjusted diluted EPS increased to $1.23, a 10% rise[6] - Adjusted Operating Margin for Q1 2025 was 15.5%, up from 15.1% in Q1 2024[32] - Adjusted Diluted Earnings Per Share (EPS) for Q1 2025 was $1.23, compared to $1.12 in Q1 2024, representing a 9.8% increase[32] - The company anticipates full-year 2025 Adjusted Diluted EPS guidance of $4.98 to $5.14[32] Shareholder Returns - The company returned $364 million to shareholders through share repurchases and dividends, with a planned return of $1.7 billion for 2025[6] - The company repurchased 2.3 million shares under its stock repurchase program during the quarter, with a remaining authorized balance of $3,047 million[44] Bookings and Growth Indicators - Trailing 12-month bookings reached $26.7 billion, reflecting a 3% year-over-year increase, with a book-to-bill ratio of approximately 1.3x[8] - The book-to-bill ratio is a key indicator of potential future revenues, with large deals defined as those with a total contract value of $100 million or greater[25] Segment Performance - The Health Sciences segment generated $1,571 million in revenue, a 10.9% increase year-over-year, contributing 30.7% to total revenues[39] - North America accounted for $3,854 million, or 75.3% of total revenues, with a year-over-year growth of 9.5%[39] - The Products and Resources segment saw a revenue increase of 12.8% year-over-year, aided by recent acquisitions contributing approximately 400 basis points to overall revenue growth[40] Financial Position - Net income for Q1 2025 was $663 million, compared to $546 million in Q1 2024, reflecting a 21.4% year-over-year growth[28] - Total current assets as of March 31, 2025, were $7,545 million, slightly up from $7,504 million at the end of 2024[30] - Total liabilities decreased to $5,068 million as of March 31, 2025, from $5,558 million at the end of 2024[30] - Cash and cash equivalents were $1,980 million as of March 31, 2025, down from $2,231 million at the end of 2024[30] - Long-term debt decreased from $875 million at December 31, 2024, to $567 million as of March 31, 2025[37] Cash Flow - Net cash provided by operating activities was $400 million, compared to $95 million in the same period last year[42] - Free cash flow for the three months ended March 31, 2025, was $393 million, significantly up from $16 million in the prior year[46] - The company experienced a net cash used in investing activities of $7 million, compared to $238 million in the prior year[42] Strategic Initiatives - Cognizant's recent acquisitions contributed approximately 400 basis points to year-over-year revenue growth[3] - The company plans to establish a Cognizant Immersive Learning Center in Chennai, India, aimed at training 100,000 individuals annually[16] - Cognizant has entered into several strategic partnerships, including with Boehringer Ingelheim and Citizens Financial Group, to enhance technology capabilities and operational efficiencies[13]

Core Insights - Cognizant reported strong financial performance in Q1 2025, with revenue of $5.115 billion, reflecting a year-over-year increase of 7.5% and 8.2% in constant currency [3][9][40] - The company achieved a GAAP operating margin of 16.7%, up 210 basis points from the previous year, and an adjusted operating margin of 15.5%, which increased by 40 basis points year-over-year [3][9][40] - GAAP diluted EPS rose to $1.34, a 22% increase year-over-year, while adjusted diluted EPS increased by 10% to $1.23 [3][9][40] Financial Performance - Revenue growth was driven by recent acquisitions, contributing approximately 400 basis points to overall revenue growth [3][44] - The company returned $364 million to shareholders through share repurchases and dividends in Q1 2025, with a planned return of $1.7 billion for the full year [5][11] - Bookings for the trailing twelve months increased by 3% year-over-year to $26.7 billion, with a book-to-bill ratio of approximately 1.3x [6][9] Operational Highlights - The first quarter performance demonstrated strong operational rigor amid elevated uncertainty, with revenue exceeding guidance and adjusted operating margin expansion [5][9] - The company expects second quarter revenue to be between $5.14 billion and $5.21 billion, representing growth of 5.9% to 7.4% [15] - Full-year 2025 revenue guidance remains unchanged at $20.5 billion to $21.0 billion, with expected growth of 3.9% to 6.4% [15] Strategic Initiatives - Cognizant is focusing on AI-led transformation, leveraging its differentiated AI and platform capabilities to assist clients in navigating macroeconomic challenges [2][14] - Recent client agreements and partnerships include collaborations with Boehringer Ingelheim, Citizens Financial Group, and Docusign, aimed at enhancing operational efficiencies and driving innovation [16][20] - The company plans to establish a Cognizant Immersive Learning Center in Chennai, India, to train 100,000 individuals annually, reflecting its commitment to workforce development [20]

Group 1 - The upcoming report from Cognizant (CTSH) is expected to reveal quarterly earnings of $1.19 per share, indicating an increase of 6.3% compared to the year-ago period [1] - Analysts forecast revenues of $5.07 billion, representing an increase of 6.5% year over year [1] - The consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days, reflecting a reevaluation of initial estimates by analysts [1] Group 2 - The consensus estimate for 'Revenue- Products and Resources' stands at $1.27 billion, suggesting a change of +12.2% year over year [4] - The average prediction for 'Revenue- Health Sciences' is $1.55 billion, indicating a change of +9.7% from the year-ago quarter [4] - Analysts suggest that 'Revenue- Financial services' will likely reach $1.43 billion, with a change of +3.2% from the year-ago quarter [4] Group 3 - The consensus among analysts for 'Revenue- Communications, Media and Technology' is expected to reach $835.39 million, indicating a year-over-year change of +1.1% [5] - Shares of Cognizant have demonstrated returns of -5.1% over the past month compared to the Zacks S&P 500 composite's -0.8% change [5] - Cognizant holds a Zacks Rank 3 (Hold), indicating expectations to mirror overall market performance in the near future [5]